<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-10-07" version="214">
<accession>Q01167</accession>
<accession>A6NEP5</accession>
<accession>Q13622</accession>
<accession>Q13623</accession>
<accession>Q13624</accession>
<name>FOXK2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="32">Forkhead box protein K2</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="31">G/T-mismatch specific binding protein</fullName>
<shortName evidence="31">nGTBP</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="27 30">Interleukin enhancer-binding factor 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FOXK2</name>
<name type="synonym" evidence="28 30">ILF</name>
<name type="synonym" evidence="27">ILF1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="7739" last="7743">
<title>Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat.</title>
<authorList>
<person name="Li C."/>
<person name="Lai C."/>
<person name="Sigman D.S."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="1909027"/>
<dbReference type="DOI" id="10.1073/pnas.88.17.7739"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Genomics" volume="13" first="665" last="671">
<title>Characterization and chromosomal mapping of the gene encoding the cellular DNA binding protein ILF.</title>
<authorList>
<person name="Li C."/>
<person name="Lusis A.J."/>
<person name="Sparkes R."/>
<person name="Nirula A."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="1339390"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90139-j"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Lymphoid tissue</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1996-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Nirula A."/>
<person name="Moore D.J."/>
<person name="Li C."/>
<person name="Gaynor R.B."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION (ISOFORMS 1; 2 AND 3)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398 AND SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="J. Biochem." volume="147" first="705" last="709">
<title>FOXK2 transcription factor is a novel G/T-mismatch DNA binding protein.</title>
<authorList>
<person name="Fujii Y."/>
<person name="Nakamura M."/>
</authorList>
<dbReference type="PubMed" id="20097901"/>
<dbReference type="DOI" id="10.1093/jb/mvq004"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="35728" last="35739">
<title>Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK.cyclin complexes.</title>
<authorList>
<person name="Marais A."/>
<person name="Ji Z."/>
<person name="Child E.S."/>
<person name="Krause E."/>
<person name="Mann D.J."/>
<person name="Sharrocks A.D."/>
</authorList>
<dbReference type="PubMed" id="20810654"/>
<dbReference type="DOI" id="10.1074/jbc.m110.154005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-373 AND SER-428</scope>
<scope>MUTAGENESIS OF SER-373 AND SER-428</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-398; SER-424 AND SER-428</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="385" last="398">
<title>The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation.</title>
<authorList>
<person name="Ji Z."/>
<person name="Donaldson I.J."/>
<person name="Liu J."/>
<person name="Hayes A."/>
<person name="Zeef L.A."/>
<person name="Sharrocks A.D."/>
</authorList>
<dbReference type="PubMed" id="22083952"/>
<dbReference type="DOI" id="10.1128/mcb.05504-11"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-398; SER-424 AND SER-428</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-144</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-527</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="6232" last="6242">
<title>The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.</title>
<authorList>
<person name="Ji Z."/>
<person name="Mohammed H."/>
<person name="Webber A."/>
<person name="Ridsdale J."/>
<person name="Han N."/>
<person name="Carroll J.S."/>
<person name="Sharrocks A.D."/>
</authorList>
<dbReference type="PubMed" id="24748658"/>
<dbReference type="DOI" id="10.1093/nar/gku274"/>
</citation>
<scope>INTERACTION WITH BAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-58</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Dev. Cell" volume="32" first="707" last="718">
<title>FOXKs promote Wnt/beta-catenin signaling by translocating DVL into the nucleus.</title>
<authorList>
<person name="Wang W."/>
<person name="Li X."/>
<person name="Lee M."/>
<person name="Jun S."/>
<person name="Aziz K.E."/>
<person name="Feng L."/>
<person name="Tran M.K."/>
<person name="Li N."/>
<person name="McCrea P.D."/>
<person name="Park J.I."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="25805136"/>
<dbReference type="DOI" id="10.1016/j.devcel.2015.01.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DVL1; DVL2; DVL3 AND SUDS3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-129; ARG-130; GLY-131; PRO-133; GLN-136; LEU-137; PRO-138; CYS-141; THR-142; PHE-145; PRO-146; SER-147; THR-148; ILE-150; LYS-151; ILE-152; PHE-154; THR-155; LEU-157 AND HIS-308</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="1580" last="1591">
<title>BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.</title>
<authorList>
<person name="Okino Y."/>
<person name="Machida Y."/>
<person name="Frankland-Searby S."/>
<person name="Machida Y.J."/>
</authorList>
<dbReference type="PubMed" id="25451922"/>
<dbReference type="DOI" id="10.1074/jbc.m114.609834"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BAP1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-161; LYS-164; LYS-527 AND LYS-633</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2018" name="Oncogenesis" volume="7" first="29" last="29">
<title>SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.</title>
<authorList>
<person name="Nestal de Moraes G."/>
<person name="Ji Z."/>
<person name="Fan L.Y."/>
<person name="Yao S."/>
<person name="Zona S."/>
<person name="Sharrocks A.D."/>
<person name="Lam E.W."/>
</authorList>
<dbReference type="PubMed" id="29540677"/>
<dbReference type="DOI" id="10.1038/s41389-018-0038-6"/>
</citation>
<scope>SUMOYLATION AT LYS-527 AND LYS-633</scope>
<scope>MUTAGENESIS OF LYS-527 AND LYS-633</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Proteins" volume="49" first="543" last="553">
<title>Solution structure of the DNA-binding domain of interleukin enhancer binding factor 1 (FOXK1a).</title>
<authorList>
<person name="Liu P.-P."/>
<person name="Chen Y.-C."/>
<person name="Li C."/>
<person name="Hsieh Y.-H."/>
<person name="Chen S.-W."/>
<person name="Chen S.-H."/>
<person name="Jeng W.-Y."/>
<person name="Chuang W.-J."/>
</authorList>
<dbReference type="PubMed" id="12402362"/>
<dbReference type="DOI" id="10.1002/prot.10227"/>
</citation>
<scope>STRUCTURE BY NMR OF 256-353 (ISOFORM 1)</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="17400" last="17409">
<title>Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins.</title>
<authorList>
<person name="Tsai K.-L."/>
<person name="Huang C.-Y."/>
<person name="Chang C.-H."/>
<person name="Sun Y.-J."/>
<person name="Chuang W.-J."/>
<person name="Hsiao C.-D."/>
</authorList>
<dbReference type="PubMed" id="16624804"/>
<dbReference type="DOI" id="10.1074/jbc.m600478200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 256-353 (ISOFORM 1) IN COMPLEX WITH MAGNESIUM AND DUPLEX DNA</scope>
<scope>DNA-BINDING</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF LYS-258; LYS-300; SER-305; ARG-307 AND LYS-328</scope>
</reference>
<comment type="function">
<text evidence="14 17 19 20 22 24 25">Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:22083952, PubMed:25451922). Together with FOXK1, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Together with FOXK1, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). In addition to the 5'-GTAAACA-3' DNA motif, also binds the 5'-TGANTCA-3' palindromic DNA motif, and co-associates with JUN/AP-1 to activate transcription (PubMed:22083952). Also able to bind to a minimal DNA heteroduplex containing a G/T-mismatch with 5'-TRT[G/T]NB-3' sequence (PubMed:20097901). Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta-catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027).</text>
</comment>
<comment type="subunit">
<text evidence="14 23 24 25">Component of SIN3A-, but not SIN3B-, containing multiprotein complexes (By similarity). Interacts with DVL1, DVL2 (when phosphorylated) and DVL3; the interaction induces DVL2 nuclear translocation (PubMed:25805136). Interacts with SUDS3 (PubMed:25805136). Interacts with BAP1 (when phosphorylated); leading to recruit the PR-DUB complex and repress FOXK2 target genes (PubMed:24748658, PubMed:25451922).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2509991">
<id>Q01167</id>
</interactant>
<interactant intactId="EBI-2866589">
<id>P14316</id>
<label>IRF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2509991">
<id>Q01167</id>
</interactant>
<interactant intactId="EBI-751711">
<id>P61244</id>
<label>MAX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="21 23 25">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q01167-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q01167-2</id>
<name>2</name>
<sequence type="described" ref="VSP_001559"/>
</isoform>
<isoform>
<id>Q01167-3</id>
<name>3</name>
<sequence type="described" ref="VSP_001560 VSP_001561"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="17">Expressed in both lymphoid and non-lymphoid cells.</text>
</comment>
<comment type="domain">
<text evidence="18">The C-terminal part of the DNA-binding domain may contribute to DNA recognition specificity.</text>
</comment>
<comment type="PTM">
<text evidence="21">Hyperphosphorylated during mitosis by CDK1 and, to a lower extent, CDK2 (PubMed:20810654). Phosphorylation at Ser-373 and Ser-428 affects stability by promoting degradation (PubMed:20810654).</text>
</comment>
<comment type="caution">
<text evidence="27 29 32">Was initially named FOXK1a by some reports (PubMed:12402362, PubMed:16624804). It should not be confused with FOXK1 (AC P85037) paralog.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAB02820" version="1"/>
</conflict>
<text>The N-terminal sequence differs due to frameshifts and sequencing errors.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAB02821" version="1"/>
</conflict>
<text>The N-terminal sequence differs due to frameshifts and sequencing errors.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAB02822" version="1"/>
</conflict>
<text>The N-terminal sequence differs due to frameshifts and sequencing errors.</text>
</comment>
<dbReference type="EMBL" id="X60787">
<property type="protein sequence ID" value="CAA43200.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U58196">
<property type="protein sequence ID" value="AAB02820.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U58197">
<property type="protein sequence ID" value="AAB02821.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U58198">
<property type="protein sequence ID" value="AAB02822.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC124287">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11813.1">
<molecule id="Q01167-1"/>
</dbReference>
<dbReference type="PIR" id="A41285">
<property type="entry name" value="A41285"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004505.2">
<molecule id="Q01167-1"/>
<property type="nucleotide sequence ID" value="NM_004514.3"/>
</dbReference>
<dbReference type="PDB" id="1JXS">
<property type="method" value="NMR"/>
<property type="chains" value="A=256-353"/>
</dbReference>
<dbReference type="PDB" id="2C6Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=256-353"/>
</dbReference>
<dbReference type="PDBsum" id="1JXS"/>
<dbReference type="PDBsum" id="2C6Y"/>
<dbReference type="BMRB" id="Q01167"/>
<dbReference type="SMR" id="Q01167"/>
<dbReference type="BioGRID" id="109820">
<property type="interactions" value="143"/>
</dbReference>
<dbReference type="IntAct" id="Q01167">
<property type="interactions" value="122"/>
</dbReference>
<dbReference type="MINT" id="Q01167"/>
<dbReference type="STRING" id="9606.ENSP00000335677"/>
<dbReference type="iPTMnet" id="Q01167"/>
<dbReference type="PhosphoSitePlus" id="Q01167"/>
<dbReference type="BioMuta" id="FOXK2"/>
<dbReference type="DMDM" id="118572648"/>
<dbReference type="EPD" id="Q01167"/>
<dbReference type="jPOST" id="Q01167"/>
<dbReference type="MassIVE" id="Q01167"/>
<dbReference type="MaxQB" id="Q01167"/>
<dbReference type="PaxDb" id="Q01167"/>
<dbReference type="PeptideAtlas" id="Q01167"/>
<dbReference type="PRIDE" id="Q01167"/>
<dbReference type="ProteomicsDB" id="57924">
<molecule id="Q01167-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57925">
<molecule id="Q01167-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57926">
<molecule id="Q01167-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="33026">
<property type="antibodies" value="227 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000335255">
<molecule id="Q01167-1"/>
<property type="protein sequence ID" value="ENSP00000335677"/>
<property type="gene ID" value="ENSG00000141568"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000473637">
<molecule id="Q01167-2"/>
<property type="protein sequence ID" value="ENSP00000436108"/>
<property type="gene ID" value="ENSG00000141568"/>
</dbReference>
<dbReference type="GeneID" id="3607"/>
<dbReference type="KEGG" id="hsa:3607"/>
<dbReference type="UCSC" id="uc002kfm.2">
<molecule id="Q01167-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3607"/>
<dbReference type="DisGeNET" id="3607"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141568.19"/>
<dbReference type="GeneCards" id="FOXK2"/>
<dbReference type="HGNC" id="HGNC:6036">
<property type="gene designation" value="FOXK2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000141568">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="147685">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q01167"/>
<dbReference type="OpenTargets" id="ENSG00000141568"/>
<dbReference type="PharmGKB" id="PA29851"/>
<dbReference type="eggNOG" id="KOG2294">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155709"/>
<dbReference type="HOGENOM" id="CLU_022344_0_0_1"/>
<dbReference type="InParanoid" id="Q01167"/>
<dbReference type="KO" id="K09404"/>
<dbReference type="OMA" id="MDQAFRK"/>
<dbReference type="OrthoDB" id="1270467at2759"/>
<dbReference type="PhylomeDB" id="Q01167"/>
<dbReference type="TreeFam" id="TF325718"/>
<dbReference type="PathwayCommons" id="Q01167"/>
<dbReference type="Reactome" id="R-HSA-5689603">
<property type="pathway name" value="UCH proteinases"/>
</dbReference>
<dbReference type="SIGNOR" id="Q01167"/>
<dbReference type="BioGRID-ORCS" id="3607">
<property type="hits" value="13 hits in 891 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FOXK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q01167"/>
<dbReference type="GeneWiki" id="FOXK2"/>
<dbReference type="GenomeRNAi" id="3607"/>
<dbReference type="Pharos" id="Q01167">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q01167"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q01167">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141568">
<property type="expression patterns" value="Expressed in adrenal tissue and 237 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q01167">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q01167">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061621">
<property type="term" value="P:canonical glycolysis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001678">
<property type="term" value="P:cellular glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010906">
<property type="term" value="P:regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042594">
<property type="term" value="P:response to starvation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00059">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00060">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00065"/>
<dbReference type="InterPro" id="IPR000253">
<property type="entry name" value="FHA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001766">
<property type="entry name" value="Fork_head_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018122">
<property type="entry name" value="TF_fork_head_CS_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR030456">
<property type="entry name" value="TF_fork_head_CS_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00498">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00250">
<property type="entry name" value="Forkhead"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00053">
<property type="entry name" value="FORKHEAD"/>
</dbReference>
<dbReference type="SMART" id="SM00339">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00240">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50006">
<property type="entry name" value="FHA_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00657">
<property type="entry name" value="FORK_HEAD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00658">
<property type="entry name" value="FORK_HEAD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50039">
<property type="entry name" value="FORK_HEAD_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="5 7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Forkhead box protein K2" id="PRO_0000091858">
<location>
<begin position="2"/>
<end position="660"/>
</location>
</feature>
<feature type="domain" description="FHA" evidence="15">
<location>
<begin position="54"/>
<end position="128"/>
</location>
</feature>
<feature type="DNA-binding region" description="Fork-head" evidence="16">
<location>
<begin position="258"/>
<end position="353"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with DVL2 and SUDS3" evidence="25">
<location>
<begin position="129"/>
<end position="171"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding; major groove" evidence="18">
<location>
<begin position="300"/>
<end position="318"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding; minor groove" evidence="18">
<location>
<begin position="328"/>
<end position="332"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding; minor groove" evidence="18">
<location>
<begin position="348"/>
<end position="353"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="10"/>
<end position="93"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; via carbonyl oxygen" evidence="18">
<location>
<position position="310"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; via carbonyl oxygen" evidence="18">
<location>
<position position="311"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; via carbonyl oxygen" evidence="18">
<location>
<position position="313"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; via carbonyl oxygen" evidence="18">
<location>
<position position="316"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="5 7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="30"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="10">
<location>
<position position="144"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 9">
<location>
<position position="239"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="21">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 9 11">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9">
<location>
<position position="424"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="4 6 7 9 21">
<location>
<position position="428"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="599"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="161"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="164"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12 13 26">
<location>
<position position="527"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13 26">
<location>
<position position="633"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_001560" evidence="32">
<original>NSIRHNLSLNRYFIKVPRSQEEPGK</original>
<variation>RGESFAHVGNTRIRIGLPAHKAPQR</variation>
<location>
<begin position="304"/>
<end position="328"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_001561" evidence="32">
<location>
<begin position="329"/>
<end position="660"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001559" evidence="28">
<original>AAASPLHMLATHASASASLPTKRHNGDQPEQPELKRIKTEDGEGIVIALSVDTPPAAVREKGVQN</original>
<variation>GPLGLRRPPCASSDWSCLS</variation>
<location>
<begin position="596"/>
<end position="660"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with BAP1." evidence="23">
<original>R</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>R</original>
<variation>A</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>R</original>
<variation>A</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>G</original>
<variation>A</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>P</original>
<variation>A</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>Q</original>
<variation>A</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation." evidence="25">
<original>L</original>
<variation>A</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>P</original>
<variation>A</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>C</original>
<variation>A</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation." evidence="25">
<original>F</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Highly reduces interaction with DVL2." evidence="25">
<original>P</original>
<variation>A</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>I</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>I</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with DVL2 and SUDS3 as well as DVL2 nuclear translocation." evidence="25">
<original>F</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>L</original>
<variation>A</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases DNA-binding to 40%." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases DNA-binding to 20%." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases DNA-binding to 70%." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with DVL2." evidence="25">
<original>H</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases DNA-binding to 25%." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased phosphorylation leading to increased stability of the protein; when associated with A-428." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant; decreased phosphorylation leading to decreased stability of the protein; when associated with D-428." evidence="21">
<original>S</original>
<variation>D</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased phosphorylation leading to increased stability of the protein; when associated with A-373." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant; decreased phosphorylation leading to decreased stability of the protein; when associated with D-373." evidence="21">
<original>S</original>
<variation>D</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished SUMOylation; when associated with R-633." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished SUMOylation; when associated with R-527." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="633"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA43200." ref="1" evidence="32">
<original>AAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSMGHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNG</original>
<variation>Q</variation>
<location>
<begin position="3"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="263"/>
<end position="272"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="281"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="295"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="300"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="316"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="324"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="331"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="336"/>
<end position="346"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JXS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2C6Y"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3UCQ1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00086"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00089"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1339390"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16624804"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1909027"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20097901"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20810654"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22083952"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24748658"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25451922"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25805136"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29540677"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12402362"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1339390"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16624804"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1909027"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20097901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="660" mass="69062" checksum="E11C0B24370F1260" modified="2006-11-28" version="3">MAAAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSMGHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNGVFVDGVFQRRGAPPLQLPRVCTFRFPSTNIKITFTALSSEKREKQEASESPVKAVQPHISPLTINIPDTMAHLISPLPSPTGTISAANSCPSSPRGAGSSGYKVGRVMPSDLNLMADNSQPENEKEASGGDSPKDDSKPPYSYAQLIVQAITMAPDKQLTLNGIYTHITKNYPYYRTADKGWQNSIRHNLSLNRYFIKVPRSQEEPGKGSFWRIDPASESKLIEQAFRKRRPRGVPCFRTPLGPLSSRSAPASPNHAGVLSAHSSGAQTPESLSREGSPAPLEPEPGAAQPKLAVIQEARFAQSAPGSPLSSQPVLITVQRQLPQAIKPVTYTVATPVTTSTSQPPVVQTVHVVHQIPAVSVTSVAGLAPANTYTVSGQAVVTPAAVLAPPKAEAQENGDHREVKVKVEPIPAIGHATLGTASRIIQTAQTTPVQTVTIVQQAPLGQHQLPIKTVTQNGTHVASVPTAVHGQVNNAAASPLHMLATHASASASLPTKRHNGDQPEQPELKRIKTEDGEGIVIALSVDTPPAAVREKGVQN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

